Skip to main content

Table 1 Characteristics of the included population

From: One-year follow-up healthcare costs of patients diagnosed with skin cancer in Germany: a claims data analysis

  MM NMSC
Routine SCS Control Total Routine SCS Control Total
n 6480 7153 13,633 43,308 74,860 118,168
Female sex, % 49.4* 54.4* 52.0 51.4* 53.5* 52.7
Age: mean (median) 63.3* (64.4) 66.2* (67.9) 64.8 (66.1) 70.8* (73.7) 74.0* (76.2) 72.8 (75.3)
Elixhauser Comorbidity Index, pre-observation period
 Mean 3.14* 3.51* 3.34 3.74* 4.13* 3.99
 Median 3 3 3 3 4 4
 SD 2.63 2.74 2.69 2.70 2.78 2.76
 Min 0 0 0 0 0 0
 Max 16 19 19 18 18 18
Pharmacy-based Metric, pre-observation period
 Mean 3.20* 3.55* 3.39 3.69* 4.07* 3.93
 Median 3 3 3 3 4 4
 SD 2.36 2.47 2.42 2.39 2.47 2.45
 Min 0 0 0 0 0 0
 Max 14 14 14 16 17 17
  1. SCS skin cancer screening, SD standard deviation
  2. *significant difference according to Mann–Whitney-U-test between routine SCS and control, p < 0.05